Bangladesh
As of 05/21/2025, Navana Pharmaceuticals PLC's market capitalization has reached $42.75 M. According to our data, Navana Pharmaceuticals PLC is the 30337th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 42.75 M |
| Revenue (ttm) | 68.80 M |
| Net Income (ttm) | 3.64 M |
| Shares Out | 107.42 M |
| EPS (ttm) | 0.03 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 11/20/2024 |
| Earnings Date | 10/21/2025 |
| Date | Market Cap(BDT) | Change (%) |
|---|---|---|
| 05/21/2025 | 5.26 B | 0.21% |
| 12/30/2024 | 5.22 B | -42.42% |
| 12/28/2023 | 9.07 B | 7.79% |
| 12/29/2022 | 8.41 B |
Navana Pharmaceuticals PLC is a leading pharmaceutical and veterinary products company based in Bangladesh. Established in 1986, the company specializes in:
Headquartered in Dhaka, Bangladesh, Navana Pharmaceuticals PLC plays a vital role in the country's healthcare sector.
| Country or region | Bangladesh |
| Founded | 1986 |
| IPO Date | n/a |
| Employees | 4,408 |
| CEO | Md. Shafiq |
| Sector | |
| Industry | Pharmaceutical Preparations |
| Address |
House 99 Dhaka, 1213 Bangladesh |
| Website | https://www.navanapharma.com |